Search research articles
Contact Us
Filters
Showing results (161-170 of 170) with videos related to
Page
of 17
Sort By:
You have reached the last page of results.
This site can display upto 170 results.
The New England Journal of Medicine
|
May 5, 2021
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
Susan E Dorman, Payam Nahid, Ekaterina V Kurbatova, et al.
Contemporary Clinical Trials
|
January 26, 2020
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial
Susan E Dorman, Payam Nahid, Ekaterina V Kurbatova, et al.
The Lancet. Infectious Diseases
|
March 8, 2014
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial
Beatriz Grinsztejn, Mina C Hosseinipour, Heather J Ribaudo, et al.
Medicine
|
February 13, 2016
The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial
Warren Dinges, Pierre-Marie Girard, Daniel Podzamczer, et al.
The New England Journal of Medicine
|
July 20, 2011
Prevention of HIV-1 infection with early antiretroviral therapy
Myron S Cohen, Ying Q Chen, Marybeth McCauley, et al.
The New England Journal of Medicine
|
July 19, 2016
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
Myron S Cohen, Ying Q Chen, Marybeth McCauley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 2, 2020
Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials
Giuliano Rizzardini, Edgar T Overton, Chloe Orkin, et al.
Annals of Internal Medicine
|
September 30, 2024
National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned
Roy M Gulick, Alice K Pau, Eric Daar, et al.
The Lancet. Infectious Diseases
|
November 20, 2021
Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis
Ashar Dhana, Yohhei Hamada, Andre P Kengne, et al.
Annals of Internal Medicine
|
June 14, 2021
Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19
Safia Kuriakose, Kanal Singh, Alice K Pau, et al.
Page
of 17
Search research articles
Search
Showing results (161-170 of 170) with videos related to
Sort By:
Page
of 17
You have reached the last page of results.
This site can display upto 170 results.
The New England Journal of Medicine
|
May 5, 2021
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
Susan E Dorman, Payam Nahid, Ekaterina V Kurbatova, et al.
Contemporary Clinical Trials
|
January 26, 2020
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial
Susan E Dorman, Payam Nahid, Ekaterina V Kurbatova, et al.
The Lancet. Infectious Diseases
|
March 8, 2014
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial
Beatriz Grinsztejn, Mina C Hosseinipour, Heather J Ribaudo, et al.
Medicine
|
February 13, 2016
The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial
Warren Dinges, Pierre-Marie Girard, Daniel Podzamczer, et al.
The New England Journal of Medicine
|
July 20, 2011
Prevention of HIV-1 infection with early antiretroviral therapy
Myron S Cohen, Ying Q Chen, Marybeth McCauley, et al.
The New England Journal of Medicine
|
July 19, 2016
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
Myron S Cohen, Ying Q Chen, Marybeth McCauley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 2, 2020
Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials
Giuliano Rizzardini, Edgar T Overton, Chloe Orkin, et al.
Annals of Internal Medicine
|
September 30, 2024
National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned
Roy M Gulick, Alice K Pau, Eric Daar, et al.
The Lancet. Infectious Diseases
|
November 20, 2021
Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis
Ashar Dhana, Yohhei Hamada, Andre P Kengne, et al.
Annals of Internal Medicine
|
June 14, 2021
Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19
Safia Kuriakose, Kanal Singh, Alice K Pau, et al.
Page
of 17